AFBSX
Price
$22.29
Change
+$0.02 (+0.09%)
Updated
Sep 14 closing price
Net Assets
624.41K
RYILX
Price
$48.59
Change
+$0.12 (+0.25%)
Updated
Sep 14 closing price
Net Assets
15.38M
Interact to see
Advertisement

AFBSX vs RYILX

AFBSX vs RYILX Comparison Chart in %
View a ticker or compare two or three
VS
AFBSX vs. RYILX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFBSX is a Hold and RYILX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYILX has more cash in the bank: 15.4M vs. AFBSX (624K). AFBSX (0.00) and RYILX (0.00) have matching dividends . AFBSX was incepted earlier than RYILX: AFBSX (21 years) vs RYILX (19 years). AFBSX (6.34) is less costly to investors than RYILX (1.72). RYILX has a lower initial minimum investment than AFBSX: RYILX (2500) vs AFBSX (15000). AFBSX IRA initial investment is lower compared to RYILX: AFBSX (15000) vs RYILX (1000). RYILX annual gain was more profitable for investors over the last year : 3.81 vs. AFBSX (-2.71). RYILX return over 5 years is better than : 3.54 vs. AFBSX (-12.22).
AFBSXRYILXAFBSX / RYILX
Total Expense Ratio2.781.64170%
Annual Report Gross Expense Ratio6.341.72369%
Fund Existence21 years19 years-
Gain YTD-1.4174.147-34%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRA1500010001,500%
Net Assets624K15.4M4%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.713.81-71%
Returns for 3 years-16.22-4.66348%
Returns for 5 years-12.223.54-345%
Returns for 10 years-39.73-22.57176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLRHX27.020.31
+1.16%
Nomura Healthcare Fund Class R
LGLOX60.26N/A
N/A
Lord Abbett Growth Leaders F3
STCAX18.53N/A
N/A
Virtus Silvant Large-Cap Growth Stk I
LMOPX48.62N/A
N/A
Patient Opportunity C
POIRX14.40N/A
N/A
Polen International Growth Investor